Sanofi Sarclisa approved in EU for transplant-eligible newly diagnosed multiple myeloma

Paris: Sanofi has announced that the European Commission has approved Sarclisa in combination with bortezomib, lenalidomide, and dexamethasone (VRd) for the induction treatment of adult patients with newly diagnosed multiple myeloma…

Continue ReadingSanofi Sarclisa approved in EU for transplant-eligible newly diagnosed multiple myeloma

Alembic Pharma gets USFDA nod for anticonvulsant drug Carbamazepine Extended Release

Vadodara: An Indian multinational pharmaceutical company, Alembic Pharmaceuticals Limited, today announced that the company has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug…

Continue ReadingAlembic Pharma gets USFDA nod for anticonvulsant drug Carbamazepine Extended Release

NEET PG 2025 exam centre chaos: Aspirants decry cross-state allotments, urgent intervention sought

New Delhi: With just one week left until the National Eligibility-Entrance Test Postgraduate (NEET-PG) 2025 Examination, scheduled for August 3, 2025, candidates for the PG medical entrance test are concerned about…

Continue ReadingNEET PG 2025 exam centre chaos: Aspirants decry cross-state allotments, urgent intervention sought